A carregar...
A case of tumor lysis syndrome and acute renal failure associated with elotuzumab treatment in multiple myeloma
Renal dysfunction is a common comorbidity of multiple myeloma. However, tumor lysis syndrome is a rare cause of renal dysfunction in multiple myeloma. Elotuzumab is a newly US FDA-approved monoclonal antibody used in the treatment of refractory multiple myeloma. To our knowledge, elotuzumab has not...
Na minha lista:
| Publicado no: | Clin Nephrol Case Stud |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dustri-Verlag Dr. Karl Feistle
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5715206/ https://ncbi.nlm.nih.gov/pubmed/29318105 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5414/CNCS109165 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|